Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction

The protective effect of dual antiplatelet therapy (DAPT) following acute coronary syndrome is undisputed, but its duration is subject of debate. Several studies show that prolonged therapy provides a clinical benefit in patients following acute coronary syndrome. The aim of this position paper auth...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Thomas W., Aichinger, Josef, Huber, Kurt, Speidl, Walter S., Watzinger, Norbert, Zweiker, Robert, Alber, Hannes F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916195/
https://www.ncbi.nlm.nih.gov/pubmed/27278134
http://dx.doi.org/10.1007/s00508-016-1016-7
Descripción
Sumario:The protective effect of dual antiplatelet therapy (DAPT) following acute coronary syndrome is undisputed, but its duration is subject of debate. Several studies show that prolonged therapy provides a clinical benefit in patients following acute coronary syndrome. The aim of this position paper authored by Austrian experts is to outline the current evidence and provide an overview of recent studies. It is also intended to serve as a practical guide to identify those patients who may benefit from prolonged DAPT.

Ejemplares similares